The Reliability and Test-Retest Stability of the Treatment Perception Questionnaire (TPQ) in the Oncology Field: A Pilot Study.

Assessment Oncology Psycho-oncology Psychosocial health Satisfaction with care Validation study

Journal

Clinical practice and epidemiology in mental health : CP & EMH
ISSN: 1745-0179
Titre abrégé: Clin Pract Epidemiol Ment Health
Pays: United Arab Emirates
ID NLM: 101245735

Informations de publication

Date de publication:
2021
Historique:
received: 18 12 2020
revised: 08 07 2021
accepted: 09 07 2021
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

Patients' satisfaction is an indicator of technical, instrumental, environmental, and interpersonal aspects of care. It shows how much the health service "as a whole organization" meets the patients' psychosocial expectations and if the health professionals combine their technical competence with relational skills. The Treatment Perception Questionnaire (TPQ) is a brief instrument developed in the United Kingdom for research with substance abuse disorder populations. The present study aimed at evaluating the reliability and test-retest stability of the TPQ Italian translation in a sample of patients with solid and blood cancers. The TPQ was administered to 263 people with solid and blood cancers. Test-retest reliability was evaluated in a subgroup of 116 participants who completed the TPQ again after 3 months. The reliability of TPQ was good. Cronbach's alpha: 0.83 (95%CI: 0.79-0.86), 0.66 (0.59-0.72), 0.71 (0.65-0.769), respectively, in the total test, and in subscales on "staff perception", and "program perception". Test-retest reliability was 0.82 (0.77-0.87). The mean difference between the first and the second assessment was 1.0 (SD = 7.1; 95% CI -0.35 to 2.33). By plotting the differences and the means of the two assessments, 5/116 cases (4.3%) were outside the upper and lower limits of agreement. This study points out good reliability and test-retest stability of the TPQ in the oncology field. The TPQ can be used to assess variation over time about satisfaction with care in patients with oncological diseases, favoring the identification of unmet patients' needs about the quality of the service.

Sections du résumé

Background UNASSIGNED
Patients' satisfaction is an indicator of technical, instrumental, environmental, and interpersonal aspects of care. It shows how much the health service "as a whole organization" meets the patients' psychosocial expectations and if the health professionals combine their technical competence with relational skills. The Treatment Perception Questionnaire (TPQ) is a brief instrument developed in the United Kingdom for research with substance abuse disorder populations. The present study aimed at evaluating the reliability and test-retest stability of the TPQ Italian translation in a sample of patients with solid and blood cancers.
Methods UNASSIGNED
The TPQ was administered to 263 people with solid and blood cancers. Test-retest reliability was evaluated in a subgroup of 116 participants who completed the TPQ again after 3 months.
Results UNASSIGNED
The reliability of TPQ was good. Cronbach's alpha: 0.83 (95%CI: 0.79-0.86), 0.66 (0.59-0.72), 0.71 (0.65-0.769), respectively, in the total test, and in subscales on "staff perception", and "program perception". Test-retest reliability was 0.82 (0.77-0.87). The mean difference between the first and the second assessment was 1.0 (SD = 7.1; 95% CI -0.35 to 2.33). By plotting the differences and the means of the two assessments, 5/116 cases (4.3%) were outside the upper and lower limits of agreement.
Conclusions UNASSIGNED
This study points out good reliability and test-retest stability of the TPQ in the oncology field. The TPQ can be used to assess variation over time about satisfaction with care in patients with oncological diseases, favoring the identification of unmet patients' needs about the quality of the service.

Identifiants

pubmed: 35444706
doi: 10.2174/1745017902117010324
pii: CPEMH-17-324
pmc: PMC8985465
doi:

Types de publication

Journal Article

Langues

eng

Pagination

324-330

Informations de copyright

© 2021 Sancassiani et al.

Références

Public Health. 2020 Feb;179:169-177
pubmed: 31855837
Psychooncology. 2012 Sep;21(9):986-92
pubmed: 21681995
Int Rev Psychiatry. 2013 Feb;25(1):19-30
pubmed: 23383664
BMJ Qual Saf. 2012 Jan;21(1):39-46
pubmed: 21873465
J Natl Cancer Inst. 2014 Sep 29;106(9):
pubmed: 25265940
Asia Pac J Clin Oncol. 2020 Apr;16(2):e91-e98
pubmed: 30334366
Psychosomatics. 2007 Mar-Apr;48(2):103-11
pubmed: 17329602
F1000Res. 2017 Dec 4;6:2083
pubmed: 29259774
Eur J Oncol Nurs. 2017 Aug;29:98-105
pubmed: 28720273
BMJ. 1992 Jun 6;304(6840):1491-4
pubmed: 1611375
Soc Sci Med. 2009 Jul;69(1):68-75
pubmed: 19446942
Lancet. 2014 Jul 5;384(9937):45-52
pubmed: 24996589
Eur Addict Res. 2000 Sep;6(3):115-22
pubmed: 11060475
Stat Methods Med Res. 1999 Jun;8(2):135-60
pubmed: 10501650
Curr Psychiatry Rep. 2010 Jun;12(3):246-54
pubmed: 20425288
Am J Med Sci. 2021 Feb;361(2):226-232
pubmed: 33097197
Eur J Cancer. 2005 Sep;41(14):2120-31
pubmed: 16182120
Cancer. 2018 Apr 15;124(8):1770-1779
pubmed: 29390165
Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):521-7
pubmed: 23664571
Bull World Health Organ. 2009 Apr;87(4):271-8
pubmed: 19551235
Psychother Psychosom. 2013;82(3):190-2
pubmed: 23548987
Bull World Health Organ. 2019 Aug 1;97(8):563-569
pubmed: 31384074
Lancet. 2013 Apr 13;381(9874):1312-22
pubmed: 23541057
Health Aff (Millwood). 2001 Nov-Dec;20(6):146-60
pubmed: 11816653
Arch Phys Med Rehabil. 2015 Oct;96(10):1810-9
pubmed: 26119464
J Psychosom Res. 2020 Jan;128:109889
pubmed: 31812103
Public Health. 2018 Oct;163:20-26
pubmed: 30041046
Qual Life Res. 2009 Aug;18(6):747-52
pubmed: 19513815
Gen Hosp Psychiatry. 2019 Jul - Aug;59:78-79
pubmed: 30638611

Auteurs

Federica Sancassiani (F)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Sara Gambino (S)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Jutta Lindert (J)

University of Applied Sciences Emden/Leer, Emden, Germany.

Lapo Sali (L)

Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.

Irene Pinna (I)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Giulia Origa (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Giulia Cossu (G)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Mario Scartozzi (M)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Antonio Preti (A)

Department of Neurosciences, University of Turin, Turin, Italy.

Classifications MeSH